Structural And Mechanical Determinants Of Airway Hyperresponsiveness
Funder
National Health and Medical Research Council
Funding Amount
$415,219.00
Summary
In asthma and chronic obstructive pulmonary disease, the capacity for airway passages to narrow is increased which limits airflow in and out of the lung and contributes to disease severity. The aim of this project is to identify the underlying physiological abnormalities producing the increased narrowing capacity. The investigations will focus on the role of the airway smooth muscle and epithelial layers that are widely implicated in driving the increased narrowing response, but for which the ev ....In asthma and chronic obstructive pulmonary disease, the capacity for airway passages to narrow is increased which limits airflow in and out of the lung and contributes to disease severity. The aim of this project is to identify the underlying physiological abnormalities producing the increased narrowing capacity. The investigations will focus on the role of the airway smooth muscle and epithelial layers that are widely implicated in driving the increased narrowing response, but for which the evidence remains circumstantial.Read moreRead less
Control Of Cardiac And Skeletal Contractility By Luminal Calcium Store Load In Health And Disease
Funder
National Health and Medical Research Council
Funding Amount
$415,138.00
Summary
Disorders affecting skeletal muscle and the heart can have life threatening effects and lead to impaired mobility and sudden cardiac death. This project will uncover the mechanisms of disorders which lead to skeletal muscle fatigue, chemotherapy induced toxicity in the heart and heart failure. Understanding these mechanisms may lead to successful gene therapy treatment and to the design of a new range of drug therapies to treat these devastating disorders.
Using Gene Delivery Tools To Understand And Treat Skeletal Muscle-related Disease
Funder
National Health and Medical Research Council
Funding Amount
$459,270.00
Summary
As a muscle biologist, I study the mechanisms that regulate skeletal muscle size, so that we can develop therapies for muscle wasting. What sets my research apart is my combination of expertise in muscle biology, and the use of recombinant viral vectors for altering the expression of specific genes exclusively in skeletal muscles. Our approaches enable us to study the inner workings of muscles in ways others cannot, and develop promising new therapies for treating muscle diseases.
The Genetic And Cellular Control Of Lymphangiogenesis In Health And Disease
Funder
National Health and Medical Research Council
Funding Amount
$475,534.00
Summary
Lymphatic vessels and veins play major roles in cardiovascular disorders. In many vascular pathologies we need an ability to promote or restrict vessel formation. This research investigates the genes that control the development of new veins and lymphatic vessels. Outcomes will include a greater understanding of how our vasculature is formed, providing new knowledge that should contribute to future lymphatic and vascular therapeutic approaches.
Patient-specific Modelling Of Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$428,065.00
Summary
Cardiovascular disease is undoubtedly the biggest killer in the developed world and accounts for 30% of all deaths in Australia; killing one Australian every twelve minutes. My research group and I, combine medical imaging with biomedical engineering to perform patient-specific modelling. For example, we can predict the likelihood that aneurysm will rupture or the way blood flows through the aorta. My goal is to make these modelling tools accurate and robust enough to be used in the clinic.
Advancing The Diagnosis And Treatment Of Inherited Muscle Disorders
Funder
National Health and Medical Research Council
Funding Amount
$408,388.00
Summary
Inherited myopathies collectively affect ~1 in 1000 people, cause life-long disability and often shortened life. This fellowship addresses two key areas of need. 1. New gene discovery for the inherited myopathies using the latest genetic techniques and 2. developing therapies. I will test two recently developed drugs as potential treatments for tropomyosin myopathies and investigate key areas of disease mechanism for tropomyosin and RYR1 myopathies to identify new therapeutic targets.
WHY YOUNG PEOPLE DEVELOP OLD KNEES: PREDICTORS OF EARLY JOINT CHANGES FOLLOWING KNEE LIGAMENT RECONSTRUCTION
Funder
National Health and Medical Research Council
Funding Amount
$415,218.00
Summary
My research investigates how muscles & movement patterns (i.e. biomechanics) contribute to early adverse knee cartilage & bone changes in young individuals at risk of developing premature knee osteoarthritis (OA): a debilitating disease causing pain & diminished quality of life. Biomechanical measures selected can be modified with interventions such as exercise & gait retraining. Ultimately, my research could reduce future risk of knee OA & its resultant personal & societal costs.